Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Explore various ways to earn side income without a traditional job, allowing for greater flexibility and freedom. Start today!
23,215 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
As July begins, the crypto market today, july shows renewed strength. Bitcoin tops 60k while other assets catch a bid...
Tesla delivered 480,126 vehicles in Q2 2026, topping estimates by 74,000 and signaling a rebound in EV demand. The fo...
Biogen’s $1 billion move on a mystery company has investors buzzing. This article breaks down why the deal could be a...
A federal judge granted Alibaba a temporary reprieve from the Defense Department lobbying ban as she weighs the compa...
The Dow’s first-half drama centered on one tech mega-cap that stood out for all the wrong reasons. This article break...
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
XRP’s leverage washout has cooled, but the next move hinges on real buying. ETFs and spot demand must prove durable t...
SK hynix prepares to begin trading on Nasdaq with ADRs priced at $149, in a move that broadens access to AI memory ex...
A modest insider sale can spark questions, but the bigger signal for investors is a company delivering solid earnings...
Weekend reads aren’t just for leisure—they’re a powerful way to sharpen investing judgment. This guide blends long-fo...
A convicted money launderer allegedly routed about $290,000 in crypto after a court ordered asset forfeiture, highlig...